Dermatomycoses is a fungal
infection of the skin commonly caused by yeast, dermatophytes or other groups
of fungi (e.g. epidermophyton, microsporum and genera trichophyton). These
organisms break down the keratin tissues of hair, epidermis, nails and are
mainly characterized by colonization of the keratinized layers on the surface
of skin. Dermatomycoses commonly refers as tinea or ring-worm infections due
to its characteristic ringed lesions. It comprises various types of ringworm
infections namely athelete’s foot, microsporosis, jock itch and
trichophytosis.
Visit Complete Report Here: http://www.marketresearchreports.biz/analysis-details/dermatomycoses-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
The possible route of entry for
these organisms (i.e. dermatophytes) into the host body is by scars, burns and
injured skin. These organisms invade into the layer of skin and spread
infection. It may cause inflammation of skin, hair folicles and nails due to
infection. Dermatomycoses leads to scaly, dry red patches on skin that slowly
spreads on the surface of the skin. Diabetes, weak immune system (e.g. AIDS),
overweight are some of the conditions that increases the risk of
dermatomycoses infection. Dermatomycoses is currently treated with
commercially available antifungal creams (such as benzoic acid, ketoconazole
and allylamine) and tablets. In addition, following proper personal hygiene
and use of protective clothing are also advisable for the control of these
types of infections.
The escalating demand for
dermatomycoses drugs has been attributed to the rise in cases of fungal
infections globally. According to World Health Organization, approximately 20%
of the world population suffers from mycosis infections and the percentage is
even higher in tropical and subtropical areas. In addition, advancements in
science and technologies that enables to develop novel and cost effective
anti-dermatophytic drugs will further drive the growth of this market.
Additionally, technological
advancements have increased the penetration ability of these drugs. This
factor permits effective and quick treatment options for fungal infections
that attracts more number of customers to use these drugs and hence stimulates
the market growth. Furthermore, diabetic patients are more susceptible to
dermatomycoses infections. Increasing number of diabetic patients will
indirectly augment the growth of this market. For example, According to
National Diabetes Information Clearinghouse (NDIC), in 2010 approximately 10.9
million U.S. people were diagnosed with diabetes and the number is increasing
every year.
However, less specific actions of
anti-fungal drugs for the treatment of dermatomycoses infections restrains the
growth of global dermatomycoses market. In addition, high rate of side effects
like constipation, hepatitis, inhibition of the synthesis of steroid hormones
and pruritis also restricts the growth of this market.
Geographically, North America
dominates the global dermatomycoses market. The growth is mainly attributed to
increase in cases of skin infections and rise in treatment seeking population
in North America. Europe is considered as the second largest region for
dermatomycoses market. Increasing uptake of anti-dermatophytic drugs coupled
with advancement in technologies drives the growth of this market in Europe.
The market of dermatomycoses in Asia-Pacific holds a strong growth as hot
climate and humid weather of this region is a favorable condition for the
development of these infectious organisms. Thus, favorable conditions may lead
to increase in cases of fungal infections that may enhance the treatment
seeking population and hence drives the growth of this market.
Various key players contributing to
this market comprises AstraZeneca PLC, Vectura Group plc, Helix BioMedix,
Inc., Aegera Therapeutics, Inc., Amplyx Pharmaceuticals, Inc., Globeimmune,
Inc., Eli Lilly and Company, Aparna Biosciences Corporation and others
This research report analyzes this
market depending on its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive
analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for
upcoming years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints. It
provides market projections for the coming years. It includes analysis of
recent developments in technology, Porter’s five force model analysis and
detailed profiles of top industry players. The report also includes a review
of micro and macro factors essential for the existing market players and new
entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point
analysis for changing competitive dynamics
- It provides a forward looking
perspective on different factors driving or restraining market
growth
- It provides a technological
growth map over time to understand the industry growth rate
- It provides a seven-year
forecast assessed on the basis of how the market is predicted to
grow
- It helps in understanding the
key product segments and their future
- It provides pin point analysis
of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed
business decisions by having complete insights of market and by making
in-depth analysis of market segments
- It provides distinctive
graphics and exemplified SWOT analysis of major market segments
Contact US: 
|
Office: United States
|
|
State Tower
90 State Street, Suite 700 Albany, NY 12207 United States |
No comments:
Post a Comment